Yahoo Search Búsqueda en la Web

Entrar

Resultado de búsqueda

  1. www.idsociety.org › practice-guideline › clostridioides-difficile-2021-focused-updateC. difficile 2021 Focused Update - IDSA

    14 de jun. de 2021 · This clinical practice guideline is a focused update on management of Clostridioides difficile infection (CDI) in adults specifically addressing the use of fidaxomicin and bezlotoxumab for the treatment of CDI.

  2. www.idsociety.org › news--publications-new › articlesIDSA And SHEA Release New Guidelines for Managing Clostridium...

    24 de jun. de 2021 · The guidelines provide recommendations for healthcare professionals who care for adults with CDI, based on new data for fidaxomicin and bezlotoxumab. The guidelines are intended to aid clinicians in determining which treatments are best for individual patient scenarios.

  3. pubmed.ncbi.nlm.nih.gov › 34164674Clinical Practice Guideline by the Infectious Diseases Society of...

    7 de sept. de 2021 · This clinical practice guideline is a focused update on management of Clostridioides difficile infection (CDI) in adults specifically addressing the use of fidaxomicin and bezlotoxumab for the treatment of CDI.

  4. www.cambridge.org › core › journalsNavigating the 2021 update to the IDSA/SHEA Clostridioides...

    25 de abr. de 2022 · The 2021 focused update to the Infections Diseases Society of America/Society for Healthcare Epidemiology of America (IDSA/SHEA) guidelines for management of Clostridioides difficile infection (CDI) prioritizes the use of fidaxomicin over vancomycin for the treatment of initial and recurrent CDI.

  5. www.idsociety.org › clinical-practice-guidelines-for-clostridium-difficileIDSA

    Aquí nos gustaría mostrarte una descripción, pero el sitio web que estás mirando no lo permite.

  6. Videos

    Ver todo

  7. reference.medscape.com › viewarticle › 962025Clostridioides Difficile guidelines (IDSA, 2021)

    3 de nov. de 2021 · Updated guidelines on the management of Clostridioides difficile infection in adults were published in September 2021 by the Infectious Diseases Society of America (IDSA) and Society for...